Ipamorelin is a pentapeptide compound that acts as a selective growth hormone-releasing peptide agonist and can effectively increase the level of growth hormone in plasma without affecting other hormones. It binds to brain receptors and selectively promotes the release of GH from the pituitary gland, and has shown high efficiency in promoting GH release in both in vivo and in vitro experiments.